Cite

HARVARD Citation

    Bandeira, I. et al. (2017). Botulinum toxin type A in the treatment of facial myotonia in Schwartz‐Jampel syndrome. Muscle & nerve. 56 (2), pp. E10-E11. [Online]. 
  
Back to record